Tetracaine Hydrochloride

CHEMBL1255654 Phase 4 承認済み Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
300.8 g/mol
LogP
Phase
4

A hydrochloride salt form of tetracaine with the same therapeutic properties. This local anesthetic is used to numb specific areas of the body before medical procedures, and is commonly used as eye drops before eye examinations or minor eye surgery, as well as in spinal anesthesia.

分子量

300.8200 g/mol

TPSA

41.60 Ų

治療領域

作用機序

Blocks voltage-gated sodium channels in nerve cell membranes, preventing the generation and conduction of nerve impulses. This produces reversible loss of sensation in the area of application.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

機序

Blocks voltage-gated sodium channels in nerve cell membranes, preventing the generation and conduction of nerve impulses. This produces reversible loss of sensation in the area of application.

2D構造

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CCCCNc1ccc(C(=O)OCCN(C)C)cc1.Cl

InChI

InChI=1S/C15H24N2O2.ClH/c1-4-5-10-16-14-8-6-13(7-9-14)15(18)19-12-11-17(2)3;/h6-9,16H,4-5,10-12H2,1-3H3;1H

Molecular Formula

C15H25ClN2O2

HBD / HBA

2 / 4

回転可能結合数

9

重原子数

20

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

よくある質問

A hydrochloride salt form of tetracaine with the same therapeutic properties. This local anesthetic is used to numb specific areas of the body before medical procedures, and is commonly used as eye drops before eye examinations or minor eye surgery, as well as in spinal anesthesia.

Blocks voltage-gated sodium channels in nerve cell membranes, preventing the generation and conduction of nerve impulses. This produces reversible loss of sensation in the area of application.

Yes, Tetracaine Hydrochloride is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1255654. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 8695. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

医学的免責事項

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.